Assyro AI

Orange Book product · Generic (ANDA)

ATORVASTATIN CALCIUM

ATORVASTATIN CALCIUM

Generic (ANDA)ANDA 204991DISCN LUPIN

At a glance

Mar 06, 2019

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 06, 2019

    7 yr 5 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ATORVASTATIN CALCIUM

Strength

EQ 10MG BASE

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

ANDA 204991

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ATORVASTATIN CALCIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.